Noel R. Rose
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Noel R. Rose has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
DeLisa Fairweather
Department of Environmental Health Sciences, Johns Hopkins University, Baltimore, MD 21205, USA
6 shared publications- C. Lynne Burek
Department of Pathology, School of Medicine, Bloomberg School of Public Health, Johns Hopkins Medical Institutions, Johns Hopkins University, Ross Research Building, 648, 720 Rutland Avenue, Baltimore, MD 21205, USA
5 shared publications Davinna L. Ligons
Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA
3 shared publicationsC L Burek
2 shared publicationsC. Lynne Burek
Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA
2 shared publications- Daniela Čiháková
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
2 shared publications
Latest Publications
- 1 December 2016
- Published by Elsevier in Journal of Autoimmunity
- Vol. 75, 20-29
Current trends in autoimmunity and the nervous system
- 1 December 2016
- Published by Elsevier in Journal of Autoimmunity
- Vol. 75, 20-29
Current trends in autoimmunity and the nervous system
- 24 June 2015
- Published by Springer Nature
- p. 143-145
Cardiac Disease, Autoimmune
- Open Access
- 1 June 2015
- Published by Elsevier in Journal of Theoretical Biology
- Vol. 375, 71-76
Molecular mimicry and clonal deletion: A fresh look
- 1 June 2015
- Published by Elsevier in Journal of Theoretical Biology
- Vol. 375, 71-76
Open AccessMolecular mimicry and clonal deletion: A fresh look
- 12 March 2014
- Published by Springer Nature
- p. 1-3
Cardiac Disease, Autoimmune
- 12 March 2014
- Published by Springer Nature
- p. 1-5
Autoimmunity, Autoimmune Diseases
- 1 October 2011
- Published by SAGE Publications in Journal of Interferon & Cytokine Research
- Vol. 31 (10) , 705-710
Critical Cytokine Pathways to Cardiac Inflammation
Infectious disease is frequently cited as a precursor of subsequent autoimmune disease in genetically susceptible hosts. However, the precise mechanisms required for the transition from infection to autoimmunity have not been well defined. We have developed a mouse model of autoimmune myocarditis initiated by infection with Coxsackievirus B3 to trace the cytokine pathways involved. We found that greater production of interleukin-1β (IL-1β) and tumor necrosis factor-α during the early innate response to virus infection is necessary and sufficient to induce a later heart-specific autoimmune disease. Severity of the autoimmune myocarditis is determined by the profile of a number of T helper 1 (Th1) and Th2 cytokines. Th2 responses are especially pronounced in the most severe forms of myocarditis where eosinophils are prominent. The Th1 pathway can lead to infiltration of the heart, but may be dampened by concurrent INF-γ production. Th17 cytokines also contribute to disease, but the signature Th17 cytokine, IL-17A, is not required for cardiac inflammation. Rather, IL-17A is needed for progression to dilated cardiomyopathy. These findings may provide useful markers to identify individuals prone to develop an autoimmune sequel after infection and suggest future early interventions.
- 1 October 2011
- Published by SAGE Publications in Journal of Interferon & Cytokine Research
- Vol. 31 (10) , 705-710
Critical Cytokine Pathways to Cardiac Inflammation
Infectious disease is frequently cited as a precursor of subsequent autoimmune disease in genetically susceptible hosts. However, the precise mechanisms required for the transition from infection to autoimmunity have not been well defined. We have developed a mouse model of autoimmune myocarditis initiated by infection with Coxsackievirus B3 to trace the cytokine pathways involved. We found that greater production of interleukin-1β (IL-1β) and tumor necrosis factor-α during the early innate response to virus infection is necessary and sufficient to induce a later heart-specific autoimmune disease. Severity of the autoimmune myocarditis is determined by the profile of a number of T helper 1 (Th1) and Th2 cytokines. Th2 responses are especially pronounced in the most severe forms of myocarditis where eosinophils are prominent. The Th1 pathway can lead to infiltration of the heart, but may be dampened by concurrent INF-γ production. Th17 cytokines also contribute to disease, but the signature Th17 cytokine, IL-17A, is not required for cardiac inflammation. Rather, IL-17A is needed for progression to dilated cardiomyopathy. These findings may provide useful markers to identify individuals prone to develop an autoimmune sequel after infection and suggest future early interventions.
- 30 September 2011
- Published by Elsevier in Journal of Autoimmunity
- Vol. 37 (2) , 88-94
The genetics of autoimmune thyroiditis: The first decade
- 30 September 2011
- Published by Elsevier in Journal of Autoimmunity
- Vol. 37 (2) , 88-94
The genetics of autoimmune thyroiditis: The first decade
- 10 August 2011
- Published by Springer Nature
- p. 1-3
Cardiac Disease, Autoimmune